NHL/ CLL Research Program now enrolling patients

Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia In excess of 80,000 patients are diagnosed with Non-Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) and in excess of 200,000 patients are living with these diseases. The more aggressive Non-Hodgkin's Lymphomas are cured 45% of the time, while, as of today, Chronic Lymphocytic Leukemia is not curable. That is the task of clinical research and new drug development. Gabrail Cancer Center, a community based cancer treatment and research center located in Canton, Ohio is announcing its commitment to enhancing...

Read More